COVID-19 vaccine in patients with Dravet syndrome: Observations and real-world experiences.
Veronica HoodAnne T BergKelly G KnuppSookyong KohLinda LauxMary Anne MeskisQuratulain Zulfiqar AliMichael Scott PerryIngrid Eileen SchefferJoseph SullivanElaine C WirrellDanielle M AndradePublished in: Epilepsia (2022)
These results indicate COVID-19 vaccination is well tolerated by individuals with DS. One main reason for vaccine hesitancy was fear of increased seizure activity, which occurred in only 13% of vaccinated individuals, and none had status epilepticus. This study provides critical and reassuring insights for caregivers and health care providers making decisions about the safety of COVID-19 vaccinations for individuals with DS.